Application
Immunofluorescence of NALP3 in K562 cells with NALP3 antibody at 20 μg/mL.
Application
Immunocytochemistry of NALP3 in K562 cells with NALP3 antibody at 2 μg/mL.
Application
Western blot analysis of NALP3 in K562 cell lysate with NALP3 antibody at 1 μg/mL (A) in the absence and (B) in the presence of blocking peptide.
IHC
(A) Immunohistochemistry analysis of NLRP3 and ERα in different intestinal tissue sections. (Scale bars, 100µm).
WB
(E) Protein expression levels of ERα, NLRP3, and Caspase-1 of LMH cells. (F–H) Quantified protein level of ERα, NLRP3, and Caspase-1 (normalized to β-actin). *P < 0.05, **P < 0.01, ***P < 0.001.
WB
(D) Protein expressions of NLRP3 inflammasome components and GSDMD-N of WT and ERα–/– mice.
WB
(B) Protein expressions of NLRP3 inflammasome components and GSDMD-N.
WB
(E) Protein expressions of NLRP3 inflammasome components and GSDMD-N.
WB
(F) Immunoblot analysis of NLRP3 inflammasome components and GSDMD-N.
WB
(J) Protein expressions of NLRP3 inflammasome components and GSDMD-N.
WB
(C) Protein levels of NLRP3, ASC and Caspase-1 in colon tissues.
WB
(C) Protein levels of NLRP3, ASC, Caspase-1 and ERα in colon tissues.
WB
(A) Protein levels of NLRP3, ASC and Caspase-1 in colon tissues.
IF
(C) Colon tissue was immunofluorescently stained with Cy5-NLRP3 antibody, PE-ASC antibody and FITC-pro-Caspase-1 antibody.